Evidence map›Paper›PMID 25663769›Full record

ArticleWorld journal of gastroenterology2015

S-phase arrest after vincristine treatment may promote hepatitis B virus replication.

Lei Xu, Zeng Tu, Ge Xu, Jie-Li Hu, Xue-Fei Cai, Xing-Xing Zhan, Yu-Wei Wang, Yuan Huang, Juan Chen, Ai-Long Huang

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Lei XuLei Xu, Zeng Tu, Ge Xu, Jie-Li Hu, Xue-Fei Cai, Yu-Wei Wang, Yuan Huang, Juan Chen, Ai-Long Huang, Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing 400016, China.
Zeng TuLei Xu, Zeng Tu, Ge Xu, Jie-Li Hu, Xue-Fei Cai, Yu-Wei Wang, Yuan Huang, Juan Chen, Ai-Long Huang, Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing 400016, China.
Ge XuLei Xu, Zeng Tu, Ge Xu, Jie-Li Hu, Xue-Fei Cai, Yu-Wei Wang, Yuan Huang, Juan Chen, Ai-Long Huang, Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing 400016, China.
Jie-Li HuLei Xu, Zeng Tu, Ge Xu, Jie-Li Hu, Xue-Fei Cai, Yu-Wei Wang, Yuan Huang, Juan Chen, Ai-Long Huang, Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing 400016, China.
Xue-Fei CaiLei Xu, Zeng Tu, Ge Xu, Jie-Li Hu, Xue-Fei Cai, Yu-Wei Wang, Yuan Huang, Juan Chen, Ai-Long Huang, Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing 400016, China.
Xing-Xing ZhanLei Xu, Zeng Tu, Ge Xu, Jie-Li Hu, Xue-Fei Cai, Yu-Wei Wang, Yuan Huang, Juan Chen, Ai-Long Huang, Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing 400016, China.
Yu-Wei WangLei Xu, Zeng Tu, Ge Xu, Jie-Li Hu, Xue-Fei Cai, Yu-Wei Wang, Yuan Huang, Juan Chen, Ai-Long Huang, Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing 400016, China.
Yuan HuangLei Xu, Zeng Tu, Ge Xu, Jie-Li Hu, Xue-Fei Cai, Yu-Wei Wang, Yuan Huang, Juan Chen, Ai-Long Huang, Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing 400016, China.
Juan ChenLei Xu, Zeng Tu, Ge Xu, Jie-Li Hu, Xue-Fei Cai, Yu-Wei Wang, Yuan Huang, Juan Chen, Ai-Long Huang, Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing 400016, China.
Ai-Long HuangLei Xu, Zeng Tu, Ge Xu, Jie-Li Hu, Xue-Fei Cai, Yu-Wei Wang, Yuan Huang, Juan Chen, Ai-Long Huang, Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing 400016, China.
Heritage Christian University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo observe the effect of vincristine on hepatitis B virus (HBV) replication in vitro and to study its possible mechanisms.

methodsVincristine was added to the cultures of two cell lines stably expressing HBV. Then, the levels of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and hepatitis B core antigen (HBcAg) in the supernatants or cytoplasm were examined using by enzyme-linked immunosorbent assay and Western blot. The HBV pregenome RNA (pgRNA) was detected using reverse transcription-PCR and real-time fluorescent quantitative PCR (RT-qPCR), and viral DNA was detected using Southern blot and RT-qPCR. Cell proliferation after drug treatment was detected using the BrdU incorporation test and the trypan blue exclusion assay. Cell cycle and cell apoptosis were examined using flow cytometry and Western blot.

resultsVincristine up-regulated HBV replication directly in vitro in a dose-dependent manner, and 24-h exposure to 0.1 μmol/L vincristine induced more than 4-fold and 3-fold increases in intracellular HBV DNA and the secretion of viral DNA, respectively. The expression of HBV pgRNA, intracellular HBsAg and HBcAg, and the secretion of HBeAg were also increased significantly after drug treatment. Most importantly, vincristine promoted the cell excretion of HBV nucleocapsids instead of HBV Dane particles, and the nucleocapsids are closely related to the HBV pathogenesis. Furthermore, vincristine inhibited the proliferation of cells stably expressing HBV. The higher the concentration of the drug, the more significant the inhibition of the cell proliferation and the stronger the HBV replication ability in cells. Flow cytometry indicated that cell cycle arrest at S-phase was responsible for the cell proliferation inhibition.

conclusionVincristine has a strong stimulatory effect on HBV replication and induces cell cycle arrest, and cell proliferation inhibition may be conducive to viral replication.

Indexed as

Antineoplastic AgentsApoptosisCell ProliferationCell SurvivalDNA ReplicationDNA, ViralDose-Response Relationship, DrugHepatitis B Core AntigensHepatitis B e AntigensHepatitis B Surface AntigensHepatitis B virusHep G2 CellsHumansLiver NeoplasmsRNA, ViralS Phase Cell Cycle CheckpointsAntineoplastic AgentsDNA, ViralHepatitis B Core AntigensHepatitis B e AntigensHepatitis B Surface AntigensRNA, ViralVincristineCell cycle arrestCytotoxic chemotherapyHepatitis B virusProliferationViral reactivation

Identifiers

PMID25663769
PMCPMC4316092
OpenAlexW1999975184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.